Thursday 6/13 Insider Buying Report: FFNW, VNRX

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy — they expect to make money. So let's look at two noteworthy recent insider buys.

At First Financial Northwest, a filing with the SEC revealed that on Wednesday, Director Kevin D. Padrick bought 17,540 shares of FFNW, for a cost of $15.05 each, for a total investment of $263,911. First Financial Northwest is trading up about 1.4% on the day Thursday. Before this latest buy, Padrick purchased FFNW at 7 other times during the past year, for a total cost of $710,142 at an average of $15.03 per share.

And on Tuesday, Director Martin Charles Faulkes bought $246,134 worth of VolitionRx, buying 79,269 shares at a cost of $3.10 a piece. Before this latest buy, Faulkes made one other buy in the past twelve months, purchasing $213,608 shares at a cost of $3.02 each. VolitionRx is trading down about 0.7% on the day Thursday. Bargain hunters are able to buy VNRX even cheaper than Faulkes did, with the stock trading as low as $2.90 in trading on Thursday which is 6.6% below Faulkes's purchase price.

VIDEO: Thursday 6/13 Insider Buying Report: FFNW, VNRX

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Other Topics


Latest Markets Videos

    BNK Invest

    BNK Invest Inc. provides investment services and information. BNK Invest owns and operates a market news family of websites including DividendChannel, ETFChannel, StockOptionsChannel, and others, which make up an investor community featuring stock message boards, ratings, research, and strategies. BNK Invest caters to investing firms and individual investors internationally.

    Learn More